Clinical Trial Update: Combination Obeticholic Acid (OCA) and Statins for Monitoring of Lipids (CONTROL) [Phase 2]

View source ↗

Summary

A Phase 2 trial update (CONTROL) investigates the combination of obeticholic acid and statins for lipid monitoring in patients with nonalcoholic steatohepatitis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Steatohepatitis

Drugs mentioned

• Obeticholic acid (obeticholic acid)
• Statins (various) (statin)

Snippet

Sponsor: Intercept Pharmaceuticals | Conditions: Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2018-06-04